Outpatient Preoperative Parenteral Nutrition in Malnourished Surgical Patients (OPPortuNity)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03926949 |
Recruitment Status :
Recruiting
First Posted : April 25, 2019
Last Update Posted : July 20, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Malnutrition Surgery | Other: Parenteral Nutrition Other: Standard Nutrition Care | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Outpatient Preoperative Parenteral Nutrition in Malnourished Surgical Patients: A Feasibility Study |
Actual Study Start Date : | October 30, 2019 |
Estimated Primary Completion Date : | July 31, 2024 |
Estimated Study Completion Date : | July 31, 2024 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Intervention group
Participants will receive parenteral nutrition (Olimel 7.6% E 1000 ml), infused over 4-5 hours at outpatient infusion clinic for 5-10 days within 14 days prior to surgery.
|
Other: Parenteral Nutrition
Olimel 7.6% E 1000 ml will be infused over 4-5 hours at outpatient infusion clinic for 5-10 days within 14 days prior to surgery.
Other Name: Olimel 7.6% E 1000 ml |
Control group
Participants will receive nutrition therapy by registered dietitians within 14 days prior to surgery. Patients with SGA B and SGA C will receive advanced nutrition care and specialized nutrition care, respectively
|
Other: Standard Nutrition Care
Participants will receive nutrition therapy by registered dietitians within 14 days prior to surgery. Patients with SGA B and SGA C will receive advanced nutrition care and specialized nutrition care, respectively. |
- Rate of parenteral nutrition completion [ Time Frame: through study completion, an average of 1 year ]Rate of parenteral nutrition completion calculated by the number of patients who can complete parenteral nutrition before surgery for 5-10 days divided by total number of patients in parenteral nutrition group
- Postoperative complications evaluated by Clavien-Dindo Classification [ Time Frame: through study completion, an average of 1 year ]Clavien-Dindo Classification classifies postoperative complications into 5 grades (grade I to grade V) from mild to severe complications Grade I: no need specific intervention Grade II: need phamacological treatment Grade III: need surgical/endoscopic/radiological intervention Grade IV: life-threatening complications requiring ICU managment Grade V: death of a patient
- Length of hospital stay [ Time Frame: through study completion, an average of 1 year ]Duration between hospital admission to discharge
- Quality of life: Short Form (SF)-12 questionnaire [ Time Frame: 5-10 days during parenteral nutrition infusion ]Quality of life evaluated by Short Form (SF)-12 questionnaire A mental component score (MCS-12) and a physical component score (PCS-12) are calculated by summation of mental and physical questions, respectively. The score range from 0-100, which the higher score means the better quality of life.
- Body weight [ Time Frame: 5-10 days during parenteral nutrition infusion ]Body weight measurement in kilograms
- Nutrition status [ Time Frame: 5-10 days during parenteral nutrition infusion ]
Nutrition status evaluated by patient-generated subjective global assessment
Patient-generated subjective global assessment divides a patient into 3 groups:
A = well-nourished B = moderately malnourished or suspected malnutrition C = severely malnourished The total score is also calculated by summation of scores from weight, food intake, gastrointestinal symptoms, activity, metabolic demand, and physical examination. It ranges from 0-55, which the lower score means the better nutrition status.
- Muscle power [ Time Frame: 5-10 days during parenteral nutrition infusion ]Muscle power evaluated by handgrip strength test
- Cost-saving [ Time Frame: through study completion, an average of 1 year ]Difference in total length of stay (primary length of stay plus length of stay during readmission) between 2 groups multiplies by estimated unit cost of inpatient hospital stay per day from Alberta Health Service
- Hospital readmission [ Time Frame: 30 days after discharge ]Readmission rate within 30 days after discharge
- Total energy from parenteral nutrition [ Time Frame: 5-10 days during parenteral nutrition infusion ]Total energy from parenteral nutrition measured by total energy in kilocalories per day multiply by total days of parenteral nutrition
- Total protein from parenteral nutrition [ Time Frame: 5-10 days during parenteral nutrition infusion ]Total protein from parenteral nutrition measured by total protein in grams per day multiply by total days of parenteral nutrition
- Acceptability, appropriateness, and feasibility of intervention measured by Acceptability, Appropriateness, and Feasibility Questionnaire [ Time Frame: through study completion, an average of 1 year ]
Acceptability, Appropriateness, and Feasibility Questionnaire included score 1 to 5
- completely disagree with intervention
- disagree with intervention
- neither agree nor disagree with intervention
- agree with intervention
- completely agree with intervention
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients 18 years of age or older
- Patients screened at risk of malnutrition by Canadian Nutrition Screening Tool (CNST) and identified as malnourished by subjective global assessment (SGA) B or C
Exclusion Criteria:
- Patients undergoing minor or laparoscopic surgery
- Pregnancy
- Patients with severe systemic diseases defined by American Society of Anesthesiologists (ASA) classification III to V
- Patients with diabetes mellitus
- Patients with planned palliative treatment
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03926949
Contact: Narisorn Lakananurak, MD | 17808865718 | lakananu@ualberta.ca | |
Contact: Leah Gramlich, MD | 17809204362 | lg3@ualberta.ca |
Canada, Alberta | |
Royal Alexandra Hospital | Recruiting |
Edmonton, Alberta, Canada, T5H 3V9 | |
Contact: Narisorn Lakananurak, MD 7808865718 lakananu@ualberta.ca | |
Contact: Leah Gramlich, MD 7809204362 lg3@ualberta.ca | |
University of Alberta Hospital | Recruiting |
Edmonton, Alberta, Canada, T6G 2B7 | |
Contact: Narisorn Lakananurak, MD 17808865718 lakananu@ualberta.ca | |
Contact: Leah Gramlich, MD 17809204362 lg3@ualberta.ca |
Principal Investigator: | Leah Gramlich, MD | University of Alberta |
Responsible Party: | University of Alberta |
ClinicalTrials.gov Identifier: | NCT03926949 |
Other Study ID Numbers: |
19G2208 |
First Posted: | April 25, 2019 Key Record Dates |
Last Update Posted: | July 20, 2023 |
Last Verified: | July 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Malnutrition Nutrition Disorders |